Home > Insider Trading > Filing (0001209191-17-020872)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1513818	Versartis Inc.	VSAR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380178	Shahzad Malik	C/O Advent Life Sciences 158 North Gower Street London X0 X0 NW1 2ND		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-03-13	16,330	$19.42	2,255,228	No	4	S	Indirect	See footnote
Common Stock	Disposition	2017-03-14	100	$19.03	2,255,128	No	4	S	Indirect	See footnote
Common Stock	Disposition	2017-03-14	46,778	$19.00	2,208,350	No	4	S	Indirect	See footnote
Common Stock	Disposition	2017-03-15	103,122	$19.08	2,105,228	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	9,200	Direct

Footnotes

The shares were sold at prices ranging from $19.35 to $19.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Securities are held by Advent Life Sciences LLP ("Advent") and Advent Life Sciences Fund I LP ("Advent Fund"). Advent is the general partner of Advent Fund. The Reporting Person is a partner of Advent, and disclaims beneficial ownership of the shares held by Advent or the Advent Fund except to the extent of his indirect pecuniary interest therein.
The shares were sold at prices ranging from $19.00 to $19.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.